Research & Prediction

Digital

The next two years will be defined by a shift from R&D (Research & Development) to R&P (Research & Prediction), facilitated by agentic AI.

News

Enhertu plus Perjeta has become the first new frontline therapy approved for advanced HER2-positive breast cancer in the EU for over a decade.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.